+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Cure of Trypanosoma brucei brucei and Trypanosoma brucei rhodesiense infections in mice with an irreversible inhibitor of S-adenosylmethionine decarboxylase



Cure of Trypanosoma brucei brucei and Trypanosoma brucei rhodesiense infections in mice with an irreversible inhibitor of S-adenosylmethionine decarboxylase



Antimicrobial Agents and ChemoTherapy 34(8): 1485-1490



A structural analog, 5'-([(Z)-4-amino-2-butenyl]methylamino)-5'-deoxy adenosine (MDL 73811), of decarboxy S-adenosyl-L-methionine, the product of the reaction catalyzed by S-adenosyl-L-methionine (AdoMet) decarboxylase (DC), was found to inhibit Trypanosoma brucei brucei AdoMet DC. The inhibition was time dependent (tau 50, 0.3 min), exhibited pseudo-first-order kinetics (Ki, 1.5 microM), and was apparently irreversible. The natural substrate of the reaction, AdoMet, protected the enzyme from inactivation, suggesting that MDL 73811 was directed at the enzyme active site and was probably catalytically activated. Administration of MDL 73811 to T. b. brucei-infected rats resulted in rapid inhibition of AdoMet DC activity, a decrease in spermidine, and an increase in putrescine in the trypanosomes isolated from treated rats. Treatment of T. b. brucei-infected mice with MDL 73811 (20 mg/kg of body weight intraperitoneally twice daily for 4 days) resulted in cures of the trypanosome infections. Additionally, drug-resistant T. brucei rhodesiense infections in mice were cured by either a combination of MDL 73811 (50 mg/kg intraperitoneally three times per day for 5 days) and relatively low oral doses of alpha-difluoromethylornithine or MDL 73811 (50 mg/kg per day for 7 days) administered alone in implanted miniosmotic pumps. These data suggest that MDL 73811 and, perhaps, other inhibitors of AdoMet DC have potential for therapeutic use in various forms of African trypanosomiasis.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 039715055

Download citation: RISBibTeXText

PMID: 1977366

DOI: 10.1128/aac.34.8.1485


Related references

Cure of murine Trypanosoma brucei rhodesiense infections with an S-adenosylmethionine decarboxylase inhibitor. Antimicrobial Agents and ChemoTherapy 36(12): 2736-2740, 1992

Effects of intermediates of methionine metabolism and nucleoside analogs on S-adenosylmethionine transport by Trypanosoma brucei brucei and a drug-resistant Trypanosoma brucei rhodesiense. Biochemical Pharmacology 56(1): 95-103, 1998

Kinetics of S-adenosylmethionine cellular transport and protein methylation in Trypanosoma brucei brucei and Trypanosoma brucei rhodesiense. Archives of Biochemistry and Biophysics 364(1): 13-18, 1999

Quantitation of genetic differences between trypanosoma brucei gambiense trypanosoma brucei rhodesiense and trypanosoma brucei brucei by restriction enzyme analysis of kinetoplast dna. Molecular & Biochemical Parasitology 3(2): 117-131, 1981

In vitro cultivation of bloodstream forms of trypanosoma brucei brucei trypanosoma brucei rhodesiense and trypanosoma brucei gambiense. Journal of Protozoology 28(4): 470-479, 1981

Enzyme variation in trypanosoma brucei ssp 2. evidence for trypanosoma brucei rhodesiense being a set of variants of trypanosoma brucei brucei. Parasitology 90(1): 89-100, 1985

Irreversible inhibition of S-adenosylmethionine decarboxylase of Trypanosoma brucei brucei by S-adenosylmethionine analogues. Biochemical Pharmacology 44(5): 905-911, 1992

Experimental infections of the chimpanzee (Pan troglodytes) with Trypanosoma brucei brucei and Trypanosoma brucei rhodesiense. Annals of Tropical Medicine and Parasitology 65(4): 471-485, 1971

In situ kinetic characterization of methylthioadenosine transport by the adenosine transporter (P2) of the African Trypanosoma brucei brucei and Trypanosoma brucei rhodesiense. Biochemical Pharmacology 61(4): 449-457, 2001

Human serum resistance of metacyclic forms of Trypanosoma brucei brucei, T. brucei rhodesiense and T. brucei gambiense. Parasitology Research 73(3): 218-223, 1987

Trisomy and chromosome size changes in hybrid trypanosomes from a genetic cross between trypanosoma brucei rhodesiense and trypanosoma brucei brucei. Molecular & Biochemical Parasitology 51(2): 189-199, 1992

Flow cytofluorimetric analysis of drug accumulation by multidrug resistant trypanosoma brucei brucei and trypanosoma brucei rhodesiense. Molecular & Biochemical Parasitology 26(1-2): 183-192, 1987

Trypanosoma brucei brucei, T. brucei gambiense, and T. brucei rhodesiense: common glycoproteins and glycoprotein oligosaccharide heterogeneity identified by lectin affinity blotting and endoglycosidase H treatment. Experimental Parasitology 63(1): 32-41, 1987

Activity of extracts and naphthoquinones from Kigelia pinnata against Trypanosoma brucei brucei and Trypanosoma brucei rhodesiense. Planta Medica 65(6): 536-540, 1999

Nonvariant antigens limited to bloodstream forms of Trypanosoma brucei brucei and Trypanosoma brucei rhodesiense. Journal of Protozoology 31(4): 541-548, 1984